One Way Links at lowest prices. 150 Permanent Links for ONLY $12 . Submit your site at http://www.1way.biz/submit.php and your site will be added to all 150 directories at http://www.toppopularstore.com/taxonomy/term/28 within 24 hours and a report will be emailed to you. If you have any queries, please contact us at http://www.toppopularstore.com/contact or talk on Yahoo Messenger (ID: toppopularstore)
Partner Links More Links |
Related News Items
Bayer's Novel Oral Anticoagulant Xarelto(R) (Rivaroxaban) Gets European Licence (Medical News Today)
Fri, 03 Oct 2008 12:06:51 GMT
Today the UK's 160,000 elective hip and knee replacement patients1 will be eligible to receive Bayer Schering Pharma's new oral anticoagulant, rivaroxaban. This follows European Commission authorisation of its licence for the prevention of venous thromboembolism (deep vein thrombosis (DVT) and pulmonary embolism (PE)), in patients undergoing elective hip or knee replacement surgery.
Read More...
Bayer's Novel Oral Anticoagulant Xarelto(R) (Rivaroxaban) Gets European Licence (PR Newswire via Yahoo! Finance)
Thu, 02 Oct 2008 10:35:00 GMT
A new drug launched today could help in the fight against what experts and campaigners are calling a 'major patient safety issue' - the prevention of hospital-acquired DVT . Xarelto, a once-daily tablet which has been shown to be significantly more effective than the existing standard treatment, injectable enoxaparin-, could help prevent unnecessary deaths from hospital-acquired DVT in patients ...
Read More...
Intellectual Property (Mondaq)
Mon, 29 Sep 2008 12:32:19 GMT
Two working groups set up by the Ministry of Education to examine copyright issues have recently published their reports, together with proposed amendments.
Read More...